Skip to content

Retrospective Study of Patients with Acute Presentation for Asthma to an Emergency Department in UK (RAPAE)

Retrospective Study Investigating the Clinical Characteristic of Patients with Acute Presentation for Asthma to the A+E Department in a Busy Acute Hospital in England UK in Era of Biological Therapy for Asthma Between Jan 2019 & Jan 2024

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06360185
Acronym
RAPAE
Enrollment
400
Registered
2024-04-11
Start date
2025-12-31
Completion date
2027-12-01
Last updated
2025-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Acute

Brief summary

Study team will obtain a list of all patients who have been seen in A+E over the past 6 years with a discharge diagnosis of asthma. Their history will be reviewed from their A+E notes. Team will obtain weight and height from Electronic prescribing tool and will obtain compliance information and past medical history from participant's GP records. Team will use participant's postcode to word out socio economic status quintile using office of national statistics tool. The following information will be taken from hospital documentation and from GP records.

Detailed description

1. How many previous admissions in past one year (12 months) 2. How many presentations to A+E in previous one year (12 months) 3. Diagnosis not confirmed therefore not on any ICS 4. Poor compliance (less than 75% of ICS and/or LABA and/or LAMA and/or leukotriene prescriptions picked up in past year) 5. Recent presentation and maintenance therapy not increased (primary care or secondary care issue) 6. Is patient overweight BMI 7. Is patient on hormonal therapy, OCP, HRT, male hormones 8. Social class quintile from post code of address using ONS calculator 9. Ethnically diverse (see appendix) 10. First Eosinophil count on index admission 11. Highest eosinophil count in past (ever) and date 12. Treatment for diabetes type 2 13. Treatment for diabetes type 1 14. Treatment for hypertension 15. Smoker ever (pack year) when gave up\_\_\_\_\_\_\_\_\_\_ After obtaining this information study team will use simple statistical methods such as frequency and associations with confidence intervals to investigate which factors are associated with frequency of presentation to A+E. They will ascertain the frequency of patients who are on maximum therapy and may benefit from biological therapy, especially if they have raised eosinophils in the past year.

Interventions

None listed

Sponsors

Norfolk and Norwich University Hospitals NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* All Asthmatics patients who attend Emergency department over 5 years

Exclusion criteria

* None Asthmatics.

Design outcomes

Primary

MeasureTime frameDescription
Change in body weight5 yearsInformation will be taken from hospital documentation and from GP records.
Change in body height5 yearsInformation will be taken from hospital documentation and from GP records.

Contacts

Primary ContactSadiyah Hand, FRPC
sadiyah.hand@nnuh.nhs.uk01603 289612
Backup ContactAshnish Sinha
ashnish.sinha@nnuh.nhs.uk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026